Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for drug-induced sleep endoscopy in obstructive sleep apnea
ChiCTR2100053973Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: Sedation success rate, Heart rate and 1 more. Started Nov 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR2100053973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053973.